Literature DB >> 448416

The two-stage excision of huge acoustic neurinomas.

P E Sheptak, P J Jannetta.   

Abstract

Total removal of huge acoustic neurinomas was carried out in 23 patients by means of a two-stage suboccipital transmeatal approach with microsurgical technique. There was no operative mortality. Good results were obtained in 18 (78%) of the patients who have returned to normal activities or full-time employment. Five patients (22%) have residual preoperative neurological deficits causing a reduced level of activity. All of these, except one, are able to care for themselves. None of the patients has had any further significant neurological deficit caused by the operative procedures. Anatomical integrity of the facial nerve was maintained in 17 patients (74%). Surgical technique, operative morbidity, and results are thoroughly discussed. The potential advantages of this technique are stressed.

Entities:  

Mesh:

Year:  1979        PMID: 448416     DOI: 10.3171/jns.1979.51.1.0037

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Staging in vestibular schwannoma surgery: a modified technique.

Authors:  Ealmaan Kim; Sung-Il Nam
Journal:  J Korean Neurosurg Soc       Date:  2008-01-20

2.  Facial nerve preservation and tumor control after gamma knife radiosurgery of unilateral acoustic tumors.

Authors:  O K Ogunrinde; L D Lunsford; J C Flickinger; A Maitz; D Kondziolka
Journal:  Skull Base Surg       Date:  1994

3.  [Results of 110 microsurgical acoustic neuroma operations].

Authors:  M Samii; G Penkert
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

4.  Staged resection of large hypervascular vestibular schwannomas in young adults.

Authors:  T Abe; H Izumiyama; Y Imaizumi; S Kobayashi; M Shimazu; K Sasaki; K Matsumoto; M Kushima
Journal:  Skull Base       Date:  2001-08

5.  Does intravascular coagulation contribute to the operative mortality for large acoustic neuromas?

Authors:  C Mattock; A Crockard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.